Neurological Implications in Cardiomyopathies

Call for Papers

Cardiomyopathies (CMPs) include hereditary or acquired hypertrophic CMP (hCMP), dilated CMP, restrictive CMP (rCMP), arrhythmogenic right ventricular cardiomyopathy (ARVC), or unclassified CMP (noncompaction, Takotsubo syndromes). CMPs may be confined to the heart or may represent cardiac involvement of neurologic disease with multiorgan affection.

CMPs may be related to neurological disease in various ways. Generally, CMPs may either secondarily cause neurological disease or may represent the cardiac manifestation of a neurological disease. Concerning the first group, CMPs may cause cerebrovascular events due to systolic dysfunction, arrhythmias, or embolic events due to intracardiac thrombus formation. Concerning the second group, CMPs may represent the cardiac manifestation of neuromuscular disorders (NMDs), which are frequently associated with cardiac disease. Knowledge and understanding of these relations has led to the development of pathogenetic concepts, definition and clinical characterisation of the conditions, and of therapeutic concepts for the care of these patients and the evaluation of the outcome of these conditions.

We invite investigators to contribute original research articles as well as review articles that will stimulate the continuing efforts to understand the relation between CMPs and cerebrovascular events and between NMDs and the development of CMPs, the development of strategies to treat these conditions, and the evaluation of their outcome. We are particularly interested in articles describing new modalities for clinical characterization of cerebral involvement in CMPs and cardiac involvement in NMDs, assessment of outcomes from treatment trials, advances in molecular genetics and molecular diagnostics, and new insights into the pathomechanism of CMPs from NMDs using animal models or humans. Potential topics include, but are not limited to:

• Clinical features and genetics of cardiomyopathies associated with neuromuscular diseases
• Neurological consequences of cardiomyopathies, including cerebrovascular and cognitive effects of heart failure, arrhythmias, and embolic stroke
• Cardiac consequences of acute neurologic injury, such as arrhythmias and myocardial infarcts following acute central neurologic injury, as well as acute LV dysfunction following central neurologic injury
• Recent developments in inherited NMDs associated with CMPs
• Advances in genetics of CMPs causing cardioembolic events and of NMDs associated with CMPs
• Latest technologies for clinical evaluation and measuring outcomes
• Mechanisms to explain the development of noncompaction using model systems
• Recent advances in the treatment of CMPs from NMDs
• The complexity of managing the patient who has both acute neurologic injury as well as cardiomyopathy and heart failure

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/cpn/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:

Lead Guest Editor

• Josef Finsterer, Danube University Krems, Postfach, Wien, Austria

Guest Editors

• Claudia Stöllberger, KAR, Juchgasse 25, Vienna, Austria
• Karim Wahbi, Myology Institute, Pitié-Salpêtrière Hospital 47-83, boulevard de l'Hôpital, Paris, France